Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient Selection.

Abbas, Hussein A; Alfayez, Mansour; Kadia, Tapan; Ravandi-Kashani, Farhad; Daver, Naval

Abbas, Hussein A; Alfayez, Mansour; Kadia, Tapan; Ravandi-Kashani, Farhad; Daver, Naval.

Afiliação

Abbas HA; Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Alfayez M; Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Kadia T; Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Ravandi-Kashani F; Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Daver N; Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

Cancer Manag Res ; 11: 8817-8828, 2019.

Article em En | MEDLINE | ID: mdl-31632141

Palavras-chave

FLT3; acute myeloid leukemia; midostaurin

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancer Manag Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Nova Zelândia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google